Scorpio Bulkers (SALT) Misses Q2 EPS by 48c

Scorpio Bulkers (NYSE: SALT) reported Q2 EPS of ($1.01), $0.48 worse than the analyst estimate of ($0.53). Revenue for the quarter came in at $17.37 million versus the consensus estimate of $17.01 million.

For earnings history and earnings-related data on Scorpio Bulkers (SALT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c